Now that you've sold your OSL shares, WELCOME to my camp!
Milsha77, you're wrong. OSL and CUV (the old Epitan) are similar. Both are dodgy as hell Both tried and failed to crack the cancer market (in the case of CUV/Epitan with a tanning agent... seriously!? OMG) Both have a warped view of statistics. (if I remember correctly Epitan wasted $$ in trials chasing statistical anomalies).
CUV got lucky, it just happened that their tanning agent had an epistatic effect for EPP sufferers. Perhaps OSL will get lucky too? something out of left field?
the cancer gig is done and dusted... last roll of the dice with investors.
OSL Price at posting:
18.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)